Small amounts of a coronavirus vaccine could be made available to certain groups of people before the end of the year, according to the Government’s chief scientific adviser.
Openly contradicting the government’s top health experts, President Donald Trump has predicted that a safe and effective vaccine against the coronavirus could be ready as early as next month and in mass distribution soon after.
Safety is “top of the list” when it comes to developing a Covid-19 vaccine, the professor leading the Oxford vaccine group has said.
Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after a pause due to a reported side effect in a patient in the UK.
Human trials of the coronavirus vaccine being developed by the University of Oxford and AstraZeneca have been put on hold owing to a reported side effect in a patient in the UK.
A pause in trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University underlines the importance of such tests being carried out properly, an expert has said.
Trials of a Covid-19 vaccine under development by AstraZeneca and Oxford University have been put on hold owing to a reported side-effect in a patient in the UK.
Preliminary results from Russian coronavirus vaccine trials suggest the candidates led to no serious adverse events and also elicit an antibody response.
Pharmaceutical giant AstraZeneca has said the first volunteers have now been dosed in its clinical trial of a new drug to help prevent and treat Covid-19.
A globally coordinated rollout of a coronavirus vaccine will be in the “interests of all countries”, the World Health Organisation’s (WHO) director general has said.
England’s chief medical officer has said it would be “foolish” to plan for winter on the basis of having a coronavirus vaccine.
Australia has ordered 25 million doses of a Covid-19 vaccine being developed by Oxford University in partnership with pharmaceutical firm AstraZeneca, the country’s prime minister said.
The Government is calling on more members of the public to register for future clinical trials into Covid-19 vaccines after an initial 100,000 volunteers signed up.
Positive coronavirus tests in the UK have hit a two-month high, following an outbreak at a sandwich factory in Northampton.
The Government has reached agreements it says will give British citizens early access to 90 million doses of two more potential Covid-19 vaccines.
A coronavirus vaccine being worked on by American researchers induces a robust immune response in healthy adults, results from early phases of clinical trials suggest.
The announcement on Tuesday by Russian president Vladimir Putin that his country was the first to approve a coronavirus vaccine has been met by doubts about the science and safety.
Experts have urged caution over Russia’s coronavirus vaccine claim, saying they have seen no evidence that suggests it is safe and effective.
The Government has signed a deal with pharmaceutical giants GlaxoSmithKline (GSK) and Sanofi Pasteur for 60 million doses of a potential Covid-19 vaccine.
The biggest test yet of an experimental Covid-19 vaccine got underway in the US on Monday with the first of some 30,000 Americans rolling up their sleeves to take part.
The coronavirus vaccine trial being run by Imperial College London will expand to additional sites across England.
There are several stages to developing a vaccine that is ready for use on the public.
Human trials of the coronavirus vaccine candidate being developed at the University of Oxford suggest it is safe and induces an immune response to Covid-19.
British drug giant GlaxoSmithKline has backed a “cutting edge” player in the race to develop a vaccine for coronavirus.
The Government has signed deals for 90 million doses of promising Covid-19 vaccines, with more in the pipeline.
The Government has signed new deals which it says will provide more than 90 million doses of Covid-19 vaccine.
The head of the United Nations has condemned any attempt by countries to steal details of coronavirus vaccine research from their rivals.
More than 100 people will take part in the next phase of clinical trials to test a new coronavirus vaccine developed at Imperial College London.
Britain, the United States and Canada have accused Russian spies of targeting scientists seeking to develop a coronavirus vaccine.
The National Cyber Security Centre (NCSC) has warned that hackers linked to the Russian intelligence services are targeting those researching a coronavirus vaccine.